Defiance Launches ZETX: The First Daily 2X Long ETF for Zeta Global Holdings Corp.

Defiance Launches ZETX: The First Daily 2X Long ETF for Zeta Global Holdings Corp. GlobeNewswire February 04, 2026 MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) — Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long ZETA ETF (ZETX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure […]

Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe

Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe 100% of customers interviewed would buy again, citing trust for primary diagnosis at scale and a partnership they can count on GlobeNewswire February 04, 2026 PHILADELPHIA, Feb. 04, 2026 (GLOBE NEWSWIRE) — Proscia(R), a software company advancing digital pathology for pathologists, scientists, and

GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights

GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights GlobeNewswire February 04, 2026 Company reported $8.2 million in cash and cash equivalents at December 31, 2025 and raised additional $6.5 million in gross proceeds in January 2026 Balance sheet strengthened to fund operations into Q1 2027 Strong Phase

Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science

Collaborative research led by ARG's Medical Affairs Team and Scientific Advisory Board reinforces the company's commitment to thyroid category leadership Allergy Research Group (ARG), a leader in evidence-based nutritional supplements, today announced the publication of a new peer-reviewed scientific paper in the International Journal of Molecular Sciences. The paper, “Energy Allocation Resilience and Endocrine Integration,”

Core AI Announces Planned Partnership with Premier Data Center Developer to Accelerate AI Infrastructure Expansion in Malaysia

(NASDAQ:CHAI), Marks Key Milestone in Global AI Data Center Initiative Provides Rapid Entry into Malaysia's High-Growth AI Data Center Market Miami, Feb. 04, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company“), a global AI-focused technology and investment platform, today announced that it entered into a Memorandum of Understanding

Core AI Announces Planned Partnership with Premier Data Center Developer to Accelerate AI Infrastructure Expansion in Malaysia

Core AI Announces Planned Partnership with Premier Data Center Developer to Accelerate AI Infrastructure Expansion in Malaysia GlobeNewswire February 04, 2026 Marks Key Milestone in Global AI Data Center Initiative Provides Rapid Entry into Malaysia's High-Growth AI Data Center Market Miami, Feb. 04, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI”

Bybit’s Mantle Vault Captures Capital Flight to Safety with 50% AUM Jump in January

Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announced another milestone for Mantle Vault on Bybit On-Chain Earn, an innovative yield-generating product launched in partnership with Mantle and Cian. Since January 8, 2026, Mantle Vault has added another US$50 million in assets under management (AUM) in just four weeks. Navigating complex conditions in a

Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman

(NASDAQ:CORT), SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) — The latest adverse development for Corcept Therapeutics (NASDAQ: CORT) concerning its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome) – relacorilant – came on January 30, 2026 when Reuters reported that the FDA “warned the company 'on several occasions' not to submit its

OZSCD wholly owned Subsidiary Varon Signs $1M Investment at $20M Valuation

(Other OTC:OZSC),(OTC US:OZSC),(OTC US:OZSCD),(Other OTC:OZSCD), WARWICK, NY, Feb. 04, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSCD) is pleased to announce that it's wholly owned subsidiary Varon Corp has entered into a US$1 Million dollar equity investment with a strategic investor at a US$20 Million valuation for Varon Corp, further strengthening the Company's

Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman

Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman GlobeNewswire February 04, 2026 SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) — The latest adverse development for Corcept Therapeutics (NASDAQ: CORT) concerning its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome)

Scroll to Top